PediatricsConsultantLive Members: Login | Register
PediatricsConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blog
Dermclinic
Photoclinic
Is It Child Abuse?
Multimedia
What's Your Diagnosis?
To ConsultantLive
Buyer's Guide
 

Home

Consultant for Pediatricians. Vol. 5 No. 2
Pages: 1  2  
Previous
 

Type 2 Diabetes Mellitus in Children:
A New Challenge for Diagnosis and Prevention

By JOSEPHINE HO, MD, DANILE PACAUD, MD, and ALEXANDER K. C. LEUNG, MD
| February 1, 2006
University of Calgary, Alberta

Dr Ho is a pediatric endocrinology fellow in the department of pediatrics at Alberta Children's Hospital, University of Calgary, Alberta, Canada. Dr Pacaud is head of the division of pediatric endocrinology at Alberta Children's Hospital and associate professor of pediatrics at the University of Calgary. Dr Leung is a pediatric consultant at Alberta Children's Hospital and clinical associate professor in the department of pediatrics at the University of Calgary.

PREVENTION AND TREATMENT OF TYPE 2 DIABETES

In children with type 2 diabetes, treatment is best accomplished through the combined efforts of a multidisciplinary team.11 Ideally, patients should have access to dietitians, nurse educators, psychologists, social workers, and physicians. Type 2 diabetes has a significant impact on the entire family, and support should be offered if needed. Lifestyle modifications should involve all family members so that everyone can benefit from healthy eating habits and exercise.

Table 4 outlines available treatment options. The most appropriate and cost-effective treatment is decreased caloric intake and increased physical activity. In fact, strategies aimed at healthy lifestyle habits for children are the best way to prevent type 2 diabetes. Improved insulin sensitivity can be gained from weight loss, exercise, and maintaining an ideal body weight.12

 

Some studies have shown that metformin(Drug information on metformin) is an effective treatment for adolescents with type 2 diabetes.13,14 A recent survey found that pediatric endocrinologists in the United States and Canada treat 44% of children who have type 2 diabetes with oral hypoglycemic agents. Among these children, 71% received metformin, 46% sulfonylureas, 9% thiazolidinediones, and 4% meglitinide.15 Unfortunately, many oral hypoglycemic agents used in adults with type 2 diabetes have not been licensed for use in the pediatric population. Until the safety and efficacy of these drugs is established, they cannot be recommended for routine clinical use.

There is a lot of experience with subcutaneous insulin injections in type 1 diabetes. Recently, such injections have been used in the early treatment of type 2 diabetes to decrease glucose toxicity and achieve target blood glucose levels.16 If appropriate lifestyle modification cannot be achieved and blood glucose targets are not maintained, it is reasonable to consider a short course of insulin therapy or metformin.

Follow-up for pediatric patients with type 2 diabetes should involve the family and a multidisciplinary team (Table 5). Children often feel well and do not see the benefits of rigorous blood glucose monitoring or dietary restrictions and exercise. The long-term risks of type 2 diabetes and the benefits of treatment are often not tangible to children. This can lead to frustration and poor compliance with treatment plans. Ongoing education and support is therefore essential in managing type 2 diabetes.

 

A unique situation faced by pediatric patients with type 2 diabetes is the transition to adult services. Issues that may arise include less frequent follow-up, different expectations of the patient, and compliance problems as the adolescent assumes sole care of his or her diabetes.

Are We Meeting The Challenge?

As the prevalence of childhood obesity increases in North America, we can expect the incidence of insulin resistance and type 2 diabetes to increase as well. Early detection of type 2 diabetes is difficult because children are often asymptomatic. Few medical options are available for pediatric patients with type 2 diabetes; the optimal therapy focuses on diet and exercise.

Management of diabetes involves changes in daily lifestyle that need to be consistent in the long term. However, health care professionals often face many barriers when treating children with diabetes.17 As noted, children may feel well and do not see any immediate benefits from treatment. Families may have socioeconomic constraints or cultural differences that can make it difficult to implement healthy lifestyles. Positive role models need to be in place to encourage children to exercise and eat healthy foods. Widespread societal adjustments must be made, including increased activity in school, changed accessibility to healthy food choices, different infrastructures to favor physical activity, safe outdoor play areas for children, and changes in advertising trends.18

In attempting to stop the development of type 2 diabetes and its complications, physicians need to focus on preventing obesity in all children--not just children in seemingly high-risk populations. The real challenge will be in overcoming barriers to implementing strategies for healthy lifestyles in our communities so that all children will benefit.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES:
1. Rosenbloom AL. Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations. Paediatr Drugs. 2002;4:209-221.
2. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345-354.
3. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am. 1997;44:307-337.
4. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000;136:664-672.
5. Silverstein JH, Rosenbloom AL. Type 2 diabetes in children. Curr Diab Rep. 2001;1:19-27.
6. Young TK, Dean HJ, Flett B, Wood-Steiman P. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr. 2000;136:365-369.
7. Fore WW. Noninsulin-dependent diabetes mellitus. The prevention of complications. Med Clin North Am. 1995;79:287-298.
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S7-S9.
9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S10-S13.
10. Valabhji J, Watson M, Cox J, et al. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med. 2003;20:416-417.
11. McKnight-Menci H, Sababu S, Kelly SD. The care of children and adolescents with type 2 diabetes. J Pediatr Nurs. 2005;20:96-106.
12. Granberry MC, Fonseca VA. Insulin resistance syndrome: options for treatment. South Med J. 1999; 92:2-15.
13. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2002;25:89-94.
14. Zuhri-Yafi MI, Brosnan PG, Hardin DS. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metabol. 2002;15 (suppl 1):541-546.
15. Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metabol. 2000;13(suppl 6): 1403-1409.
16.Sellers EA, Dean JH. Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metabol. 2004;17:1561-1564.
17. Ditmyer MM, Price JH, Telljohann SK, Rogalski F. Pediatricians' perceptions and practices regarding prevention and treatment of type 2 mellitus in children and adolescents. Arch Pediatr Adolesc Med. 2003;157:913-918.
18. Pacaud D. The growing problem of childhood obesity: what can be done about the epidemic? DC Paediatric Nutrition. 2003;1:9-12.


 
TOPIC INDEX

• ADHD
• Allergy
• Asthma
• Atopic Dermatitis
• Autism
• Bacterial Conjunctivitis
• Developmental/Genetic Disorders
• Epilepsy
• Failure to Thrive
• Food Allergies
• GI Disorders
• Lice Treatments
• Obesity
• Respiratory Tract Diseases
• Sexually Transmitted Infections
• Skin Diseases
• Vaccines
• Vitamin D Insufficiency

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Diaper Dermatoses: A Photo Essay
  • Galactorrhea of the Newborn (Witch’s Milk)
  • Genital Lesions: A Photo Essay—Part 2
  • Genital Lesions: A Photo Essay
  • Perianal Pinworms (Enterobiasis)
  • Itchy, Acne-Like Rash on a Boy’s Face and Upper Arms
  • Diaper Dermatoses: A Photo Essay
  • Selective IgA Deficiency in Children: Clinical Manifestations, Evaluation, and Management
  • Top 10 Common Medication Errors -- Drug #7 -- Ciprofloxacin
  • An Overview of Chronic Cough in Children
  • Common Medication Errors: Drug #6: Ketorolac
  • Cellulitis-Adenitis From Late-Onset Group B Streptococcus Infection
  • Go for the Glory: Pediatrics Quiz of the Week
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Top 10 Common Medication Errors—Drug #8: Carbamazepine
  • Top 10 Common Medication Errors—Drug #8: Carbamazepine
  • Top 10 Common Medication Errors—Drug #1: Acetaminophen
  • Go for the Glory: Pediatrics Quiz of the Week
  • History of Cough in an Infant and a Toddler
  • Genital Lesions: A Photo Essay
Click here to subscribe to our newsletter


 

 



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy